Global Defibrillator Market Report 2020: Market is Predicted to Grow from $9,621.2 Million to $20,281.6 Million from 2019 to 2030

Dublin, Nov. 09, 2020 (GLOBE NEWSWIRE) -- The "Defibrillator Market Research Report: By Type, Patient Type, Distribution Channel, End User - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

The revenue of the global defibrillator market is predicted to grow from $9,621.2 million to $20,281.6 million from 2019 to 2030.

There has been a sharp rise in the prevalence of cardiac diseases all over the world over the last few years. This is because of the rising consumption of fast foods and high-calorie food times, increasing adoption of sedentary lifestyles, rising incidence of smoking, and soaring obesity levels around the world.

Moreover, the increasing stress levels being caused due to the rising peer pressure, growing financial responsibilities, and long working hours, especially in the developing countries, are further augmenting the incidence of various heart-related ailments and cardiovascular diseases (CVDs), which is, in turn, boosting the global demand for defibrillators.

As per the findings of the World Health Organization (WHO), "CVDs are the major cause of death, globally. In 2016, approximately 17.9 million people died due to CVDs, representing 31% of the total deaths, globally. Of these deaths, 85% were due to heart attack and stroke." Similarly, as per the 2017 report Heart Disease and Stroke Statistics published by the American Heart Association (AHA), in the U.S., one out every three people die because of a CVD every year, which equals to, the deaths of nearly 800,000 people every year.

The Nature Reviews Cardiology journal published an article titled 'Causes and Prevention of Sudden Cardiac Death in the Elderly' in 2013, which stated that sudden cardiac arrest (SCA) was one of the major causes of death in geriatric people in the U.S. This was because of the high incidence of CHDs, congestive heart failure (CHF), and systolic dysfunction in the elderly people. Due to these factors, the sales of defibrillators are rising rapidly throughout the world.

Hence, it can be said without any hesitation that the sales of defibrillators will surge all over the world in the upcoming years, because of the growing prevalence of chronic and cardiovascular diseases (CVDs) and the presence of a soaring geriatric population in many countries around the world.

Key Topics Covered:

Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Type
1.3.2 Market Segmentation by Patient Type
1.3.3 Market Segmentation by Distribution Channel
1.3.4 Market Segmentation by End User
1.3.5 Market Segmentation by Region
1.3.6 Analysis Period
1.3.7 Market Data Reporting Unit
1.3.7.1 Volume
1.3.7.2 Value
1.4 Key Stakeholders

Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Type
4.1.1.1 ICDs
4.1.1.1.1 T-ICDs
4.1.1.1.1.1 CRT-Ds
4.1.1.1.1.2 Dual-chamber defibrillators
4.1.1.1.1.3 Single-chamber defibrillators
4.1.1.1.2 S-ICDs
4.1.1.2 External defibrillators
4.1.1.2.1 Manual defibrillators
4.1.1.2.2 AEDs
4.1.1.2.2.1 By technology
4.1.1.2.2.1.1 Fully automated
4.1.1.2.2.1.2 Semi-automated
4.1.1.2.2.2 By type
4.1.1.2.2.2.1 Non-wearable
4.1.1.2.2.2.2 Wearable
4.1.2 By Patient Type
4.1.2.1 Adult
4.1.2.2 Pediatric
4.1.3 By Distribution Channel
4.1.3.1 Direct
4.1.3.2 Indirect
4.1.4 By End User
4.1.4.1 Pre-hospital care settings
4.1.4.2 Public access settings
4.1.4.3 Home care settings
4.1.4.4 Hospitals, clinics, & cardiac centers
4.1.4.5 Others
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Growing focus on the installation of AEDs at public places
4.2.1.2 Increasing number of product launches
4.2.2 Drivers
4.2.2.1 Advancements in the defibrillation technology
4.2.2.2 Surging geriatric population
4.2.2.3 Increasing strategic measures by key players
4.2.2.4 Rising incidence of cardiac diseases
4.2.2.5 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 Product failures
4.2.3.2 Stringent regulatory norms
4.2.3.3 Impact analysis of restraints on market forecast
4.2.4 Opportunities
4.2.4.1 Awareness and training programs on defibrillation
4.3 Impact of COVID-19
4.4 Porter's Five Forces Analysis
4.5 Regulatory Scenario for Defibrillators
4.6 Reimbursement Policies

Chapter 5. Global Market Size and Forecast
5.1 By Type
5.1.1 ICDs, by Type
5.1.1.1 T-ICDs, by type
5.1.2 External Defibrillators, by Type
5.1.2.1 AEDs, by technology
5.1.2.2 AEDs, by type
5.2 By Patient Type
5.3 By Distribution Channel
5.4 By End User
5.5 By Region

Chapter 6. North America Market Size and Forecast
6.1 By Type
6.1.1 ICDs, by Type
6.1.1.1 T-ICDs, by type
6.1.2 External Defibrillators, by Type
6.1.2.1 AEDs, by technology
6.1.2.2 AEDs, by type
6.2 By Patient Type
6.3 By Distribution Channel
6.4 By End User
6.5 By Country

Chapter 7. Europe Market Size and Forecast

Chapter 8. APAC Market Size and Forecast

Chapter 9. LATAM Market Size and Forecast

Chapter 10. MEA Market Size and Forecast

Chapter 11. Major Defibrillator Markets
11.1 U.S. Market Size and Forecast
11.1.1 By Type
11.1.1.1 ICDs, by type
11.1.1.1.1 T-ICDs, by type
11.1.1.2 External defibrillators, by type
11.1.1.2.1 AEDs, by technology
11.1.1.2.2 AEDs, by type
11.1.2 By Patient Type
11.1.3 By Distribution Channel
11.1.4 By End User
11.2 Canada Market Size and Forecast
11.3 Germany Market Size and Forecast
11.4 France Market Size and Forecast
11.5 Italy Market Size and Forecast
11.6 U.K. Market Size and Forecast
11.7 Poland Market Size and Forecast
11.8 Japan Market Size and Forecast
11.9 China Market Size and Forecast
11.10 India Market Size and Forecast

Chapter 12. Competitive Landscape
12.1 Product Benchmarking of Key Players
12.2 Market Share Analysis of Key Players
12.2.1 Global ICDs Market Share Analysis
12.3 Strategic Developments of Key Players
12.3.1 Product Launches and Approvals
12.3.2 Acquisitions

Chapter 13. Company Profiles

• CU Medical System Inc.

• MicroPort Scientific Corporation

• LivaNova PLC

• Progetti S.r.l.

• Koninklijke Philips N.V.

• BIOTRONIK SE & Co. KG

• Nihon Kohden Corporation

• SCHILLER AG

• Stryker Corporation

• Shenzhen Mindray Bio-Medical Electronics Co. Ltd.

• ZOLL Medical Corporation

• Mediana Co. Ltd.

• Opto Circuits India Ltd.

• Abbott Laboratories

• Boston Scientific Corporation

• Medtronic plc

• Defibtech LLC

• Cardiac Science Corporation

For more information about this report visit https://www.researchandmarkets.com/r/b5y3kc

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900